Chemical Structure : LTI-291
CAS No.: 1919820-28-2
Catalog No.: PC-24167Not For Human Use, Lab Use Only.
Pariceract (LTI-291) is an allosteric, CNS-penetrable glucosylceramidase beta (glucocerebrosidase, GCase) activator.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $98 | In stock | |
| 10 mg | $148 | In stock | |
| 25 mg | $258 | In stock | |
| 50 mg | $428 | In stock | |
| 100 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Pariceract (LTI-291) is an allosteric, CNS-penetrable glucosylceramidase beta (glucocerebrosidase, GCase) activator.
Pariceract (LTI-291) at concentrations of 0.1 and 1.0 μM increases wild type GCase activity by 25% and 130%, respectively.
Pariceract (LTI-291) shows potential for parkinson's disease carrying a GBA1 mutation.
| M.Wt | 358.49 | |
| Formula | C20H30N4O2 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
5,7-dimethyl-N-[trans-4-(pentyloxy)cyclohexyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
|
1. den Heijer JM, et al. Br J Clin Pharmacol. 2021 Sep;87(9):3561-3573.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright